Our research group focuses on clinical research regarding nutritional assessment as diagnostic tool for evidence based dietary treatment and evaluates the effectiveness of specific dietary treatments and nutrients on different (complex) disease states, using the latest innovative technologies within our core facility of Nutritional Assessment.
Our goal is to understand mechanisms of therapy resistance of prostate cancer using relevant models, to develop novel targeted therapies and combinations thereof and demonstrate preclinical proof-of-concept.